2FHW | Signaling Protein | date | Dec 27, 2005 |
---|---|---|---|
title | Solution Structure Of Human Relaxin-3 | ||
authors | K.J.Rosengren, D.J.Craik | ||
compound | source | ||
Molecule: Relaxin 3 (Prorelaxin H3) (Insulin-Like Peptide I (Insulin-Like Peptide 7); Chain: B Fragment: Relaxin 3 B Chain Engineered: Yes |
Synthetic: Yes Other_details: This Sequence Occurs Naturally In Humans. Fo Study The Peptide Has Been Generated By Solid Phase Peptide Synthesis.; | ||
Molecule: Relaxin 3 (Prorelaxin H3) (Insulin-Like Peptide I (Insulin-Like Peptide 7); Chain: A Fragment: Relaxin 3 A Chain Engineered: Yes |
Synthetic: Yes Other_details: This Sequence Occurs Naturally In Humans. Fo Study The Peptide Has Been Generated By Solid Phase Peptide Synthesis. | ||
method | Solution NMR | ||
Primary reference | Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3., Rosengren KJ, Lin F, Bathgate RA, Tregear GW, Daly NL, Wade JD, Craik DJ, J Biol Chem. 2006 Mar 3;281(9):5845-51. Epub 2005 Dec 19. PMID:16365033 |
Data retrieval |
View 2FHW in 3D |
Visual 3D analysis of 2FHW |
Structure-derived information |
Sequence-derived information |
Other resources with information on 2FHW |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |